Global Cholera Vaccines Market Insights and Forecast to 2031

Report ID: 1750233 | Published Date: Dec 2025 | No. of Page: 105 | Base Year: 2024 | Rating: 4.7 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%)

Impact of U.S Tarrifs Analyzed 2025 

1 Report Business Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global Cholera Vaccines Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
        1.2.2 Dukoral
        1.2.3 Shanchol
        1.2.4 Vaxchora
        1.2.5 Others
    1.3 Market by Application
        1.3.1 Global Cholera Vaccines Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
        1.3.2 Oral
        1.3.3 Others
    1.4 Study Objectives
    1.5 Years Considered
2 Global Growth Trends
    2.1 Global Cholera Vaccines Market Perspective (2017-2028)
    2.2 Cholera Vaccines Growth Trends by Region
        2.2.1 Cholera Vaccines Market Size by Region: 2017 VS 2021 VS 2028
        2.2.2 Cholera Vaccines Historic Market Size by Region (2017-2022)
        2.2.3 Cholera Vaccines Forecasted Market Size by Region (2023-2028)
    2.3 Cholera Vaccines Market Dynamics
        2.3.1 Cholera Vaccines Industry Trends
        2.3.2 Cholera Vaccines Market Drivers
        2.3.3 Cholera Vaccines Market Challenges
        2.3.4 Cholera Vaccines Market Restraints
3 Competition Landscape by Key Players
    3.1 Global Top Cholera Vaccines Players by Revenue
        3.1.1 Global Top Cholera Vaccines Players by Revenue (2017-2022)
        3.1.2 Global Cholera Vaccines Revenue Market Share by Players (2017-2022)
    3.2 Global Cholera Vaccines Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    3.3 Players Covered: Ranking by Cholera Vaccines Revenue
    3.4 Global Cholera Vaccines Market Concentration Ratio
        3.4.1 Global Cholera Vaccines Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by Cholera Vaccines Revenue in 2021
    3.5 Cholera Vaccines Key Players Head office and Area Served
    3.6 Key Players Cholera Vaccines Product Solution and Service
    3.7 Date of Enter into Cholera Vaccines Market
    3.8 Mergers & Acquisitions, Expansion Plans
4 Cholera Vaccines Breakdown Data by Type
    4.1 Global Cholera Vaccines Historic Market Size by Type (2017-2022)
    4.2 Global Cholera Vaccines Forecasted Market Size by Type (2023-2028)
5 Cholera Vaccines Breakdown Data by Application
    5.1 Global Cholera Vaccines Historic Market Size by Application (2017-2022)
    5.2 Global Cholera Vaccines Forecasted Market Size by Application (2023-2028)
6 North America
    6.1 North America Cholera Vaccines Market Size (2017-2028)
    6.2 North America Cholera Vaccines Market Size by Type
        6.2.1 North America Cholera Vaccines Market Size by Type (2017-2022)
        6.2.2 North America Cholera Vaccines Market Size by Type (2023-2028)
        6.2.3 North America Cholera Vaccines Market Share by Type (2017-2028)
    6.3 North America Cholera Vaccines Market Size by Application
        6.3.1 North America Cholera Vaccines Market Size by Application (2017-2022)
        6.3.2 North America Cholera Vaccines Market Size by Application (2023-2028)
        6.3.3 North America Cholera Vaccines Market Share by Application (2017-2028)
    6.4 North America Cholera Vaccines Market Size by Country
        6.4.1 North America Cholera Vaccines Market Size by Country (2017-2022)
        6.4.2 North America Cholera Vaccines Market Size by Country (2023-2028)
        6.4.3 U.S.
        6.4.4 Canada
7 Europe
    7.1 Europe Cholera Vaccines Market Size (2017-2028)
    7.2 Europe Cholera Vaccines Market Size by Type
        7.2.1 Europe Cholera Vaccines Market Size by Type (2017-2022)
        7.2.2 Europe Cholera Vaccines Market Size by Type (2023-2028)
        7.2.3 Europe Cholera Vaccines Market Share by Type (2017-2028)
    7.3 Europe Cholera Vaccines Market Size by Application
        7.3.1 Europe Cholera Vaccines Market Size by Application (2017-2022)
        7.3.2 Europe Cholera Vaccines Market Size by Application (2023-2028)
        7.3.3 Europe Cholera Vaccines Market Share by Application (2017-2028)
    7.4 Europe Cholera Vaccines Market Size by Country
        7.4.1 Europe Cholera Vaccines Market Size by Country (2017-2022)
        7.4.2 Europe Cholera Vaccines Market Size by Country (2023-2028)
        7.4.3 Germany
        7.4.4 France
        7.4.5 U.K.
        7.4.6 Italy
        7.4.7 Russia
        7.4.8 Nordic Countries
8 Asia-Pacific
    8.1 Asia-Pacific Cholera Vaccines Market Size (2017-2028)
    8.2 Asia-Pacific Cholera Vaccines Market Size by Type
        8.2.1 Asia-Pacific Cholera Vaccines Market Size by Type (2017-2022)
        8.2.2 Asia-Pacific Cholera Vaccines Market Size by Type (2023-2028)
        8.2.3 Asia-Pacific Cholera Vaccines Market Share by Type (2017-2028)
    8.3 Asia-Pacific Cholera Vaccines Market Size by Application
        8.3.1 Asia-Pacific Cholera Vaccines Market Size by Application (2017-2022)
        8.3.2 Asia-Pacific Cholera Vaccines Market Size by Application (2023-2028)
        8.3.3 Asia-Pacific Cholera Vaccines Market Share by Application (2017-2028)
    8.4 Asia-Pacific Cholera Vaccines Market Size by Region
        8.4.1 Asia-Pacific Cholera Vaccines Market Size by Region (2017-2022)
        8.4.2 Asia-Pacific Cholera Vaccines Market Size by Region (2023-2028)
        8.4.3 China
        8.4.4 Japan
        8.4.5 South Korea
        8.4.6 Southeast Asia
        8.4.7 India
        8.4.8 Australia 
9 Latin America
    9.1 Latin America Cholera Vaccines Market Size (2017-2028)
    9.2 Latin America Cholera Vaccines Market Size by Type
        9.2.1 Latin America Cholera Vaccines Market Size by Type (2017-2022)
        9.2.2 Latin America Cholera Vaccines Market Size by Type (2023-2028)
        9.2.3 Latin America Cholera Vaccines Market Share by Type (2017-2028)
    9.3 Latin America Cholera Vaccines Market Size by Application
        9.3.1 Latin America Cholera Vaccines Market Size by Application (2017-2022)
        9.3.2 Latin America Cholera Vaccines Market Size by Application (2023-2028)
        9.3.3 Latin America Cholera Vaccines Market Share by Application (2017-2028)
    9.4 Latin America Cholera Vaccines Market Size by Country
        9.4.1 Latin America Cholera Vaccines Market Size by Country (2017-2022)
        9.4.2 Latin America Cholera Vaccines Market Size by Country (2023-2028)
        9.4.3 Mexico
        9.4.4 Brazil
10 Middle East & Africa
    10.1 Middle East & Africa Cholera Vaccines Market Size (2017-2028)
    10.2 Middle East & Africa Cholera Vaccines Market Size by Type
        10.2.1 Middle East & Africa Cholera Vaccines Market Size by Type (2017-2022)
        10.2.2 Middle East & Africa Cholera Vaccines Market Size by Type (2023-2028)
        10.2.3 Middle East & Africa Cholera Vaccines Market Share by Type (2017-2028)
    10.3 Middle East & Africa Cholera Vaccines Market Size by Application
        10.3.1 Middle East & Africa Cholera Vaccines Market Size by Application (2017-2022)
        10.3.2 Middle East & Africa Cholera Vaccines Market Size by Application (2023-2028)
        10.3.3 Middle East & Africa Cholera Vaccines Market Share by Application (2017-2028)
    10.4 Middle East & Africa Cholera Vaccines Market Size by Country
        10.4.1 Middle East & Africa Cholera Vaccines Market Size by Country (2017-2022)
        10.4.2 Middle East & Africa Cholera Vaccines Market Size by Country (2023-2028)
        10.4.3 Turkey
        10.4.4 Saudi Arabia
        10.4.5 UAE
11 Key Players Profiles
    11.1 Shantha Biotechnics Private Limited
        11.1.1 Shantha Biotechnics Private Limited Company Details
        11.1.2 Shantha Biotechnics Private Limited Business Overview
        11.1.3 Shantha Biotechnics Private Limited Cholera Vaccines Introduction
        11.1.4 Shantha Biotechnics Private Limited Revenue in Cholera Vaccines Business (2017-2022)
        11.1.5 Shantha Biotechnics Private Limited Recent Developments
    11.2 PaxVax, Inc.
        11.2.1 PaxVax, Inc. Company Details
        11.2.2 PaxVax, Inc. Business Overview
        11.2.3 PaxVax, Inc. Cholera Vaccines Introduction
        11.2.4 PaxVax, Inc. Revenue in Cholera Vaccines Business (2017-2022)
        11.2.5 PaxVax, Inc. Recent Developments
    11.3 Valneva SE
        11.3.1 Valneva SE Company Details
        11.3.2 Valneva SE Business Overview
        11.3.3 Valneva SE Cholera Vaccines Introduction
        11.3.4 Valneva SE Revenue in Cholera Vaccines Business (2017-2022)
        11.3.5 Valneva SE Recent Developments
    11.4 Merck and Co., Inc.
        11.4.1 Merck and Co., Inc. Company Details
        11.4.2 Merck and Co., Inc. Business Overview
        11.4.3 Merck and Co., Inc. Cholera Vaccines Introduction
        11.4.4 Merck and Co., Inc. Revenue in Cholera Vaccines Business (2017-2022)
        11.4.5 Merck and Co., Inc. Recent Developments
    11.5 GlaxoSmithKline plc (GSK)
        11.5.1 GlaxoSmithKline plc (GSK) Company Details
        11.5.2 GlaxoSmithKline plc (GSK) Business Overview
        11.5.3 GlaxoSmithKline plc (GSK) Cholera Vaccines Introduction
        11.5.4 GlaxoSmithKline plc (GSK) Revenue in Cholera Vaccines Business (2017-2022)
        11.5.5 GlaxoSmithKline plc (GSK) Recent Developments
    11.6 Astellas Pharma, Inc.
        11.6.1 Astellas Pharma, Inc. Company Details
        11.6.2 Astellas Pharma, Inc. Business Overview
        11.6.3 Astellas Pharma, Inc. Cholera Vaccines Introduction
        11.6.4 Astellas Pharma, Inc. Revenue in Cholera Vaccines Business (2017-2022)
        11.6.5 Astellas Pharma, Inc. Recent Developments
    11.7 Pfizer, Inc.
        11.7.1 Pfizer, Inc. Company Details
        11.7.2 Pfizer, Inc. Business Overview
        11.7.3 Pfizer, Inc. Cholera Vaccines Introduction
        11.7.4 Pfizer, Inc. Revenue in Cholera Vaccines Business (2017-2022)
        11.7.5 Pfizer, Inc. Recent Developments
    11.8 Emergent BioSolutions, Inc.
        11.8.1 Emergent BioSolutions, Inc. Company Details
        11.8.2 Emergent BioSolutions, Inc. Business Overview
        11.8.3 Emergent BioSolutions, Inc. Cholera Vaccines Introduction
        11.8.4 Emergent BioSolutions, Inc. Revenue in Cholera Vaccines Business (2017-2022)
        11.8.5 Emergent BioSolutions, Inc. Recent Developments
    11.9 Mitsubishi Tanabe Pharma Corporation
        11.9.1 Mitsubishi Tanabe Pharma Corporation Company Details
        11.9.2 Mitsubishi Tanabe Pharma Corporation Business Overview
        11.9.3 Mitsubishi Tanabe Pharma Corporation Cholera Vaccines Introduction
        11.9.4 Mitsubishi Tanabe Pharma Corporation Revenue in Cholera Vaccines Business (2017-2022)
        11.9.5 Mitsubishi Tanabe Pharma Corporation Recent Developments
    11.10 Takeda Pharmaceutical Co., Ltd.
        11.10.1 Takeda Pharmaceutical Co., Ltd. Company Details
        11.10.2 Takeda Pharmaceutical Co., Ltd. Business Overview
        11.10.3 Takeda Pharmaceutical Co., Ltd. Cholera Vaccines Introduction
        11.10.4 Takeda Pharmaceutical Co., Ltd. Revenue in Cholera Vaccines Business (2017-2022)
        11.10.5 Takeda Pharmaceutical Co., Ltd. Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Author Details
    13.3 Disclaimer

List of Tables
    Table 1. Global Cholera Vaccines Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028
    Table 2. Key Players of Dukoral
    Table 3. Key Players of Shanchol
    Table 4. Key Players of Vaxchora
    Table 5. Key Players of Others
    Table 6. Global Cholera Vaccines Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028
    Table 7. Global Cholera Vaccines Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
    Table 8. Global Cholera Vaccines Market Size by Region (2017-2022) & (US$ Million)
    Table 9. Global Cholera Vaccines Market Share by Region (2017-2022)
    Table 10. Global Cholera Vaccines Forecasted Market Size by Region (2023-2028) & (US$ Million)
    Table 11. Global Cholera Vaccines Market Share by Region (2023-2028)
    Table 12. Cholera Vaccines Market Trends
    Table 13. Cholera Vaccines Market Drivers
    Table 14. Cholera Vaccines Market Challenges
    Table 15. Cholera Vaccines Market Restraints
    Table 16. Global Cholera Vaccines Revenue by Players (2017-2022) & (US$ Million)
    Table 17. Global Cholera Vaccines Revenue Share by Players (2017-2022)
    Table 18. Global Top Cholera Vaccines by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cholera Vaccines as of 2021)
    Table 19. Ranking of Global Top Cholera Vaccines Companies by Revenue (US$ Million) in 2021
    Table 20. Global 5 Largest Players Market Share by Cholera Vaccines Revenue (CR5 and HHI) & (2017-2022)
    Table 21. Key Players Headquarters and Area Served
    Table 22. Key Players Cholera Vaccines Product Solution and Service
    Table 23. Date of Enter into Cholera Vaccines Market
    Table 24. Mergers & Acquisitions, Expansion Plans
    Table 25. Global Cholera Vaccines Market Size by Type (2017-2022) & (US$ Million)
    Table 26. Global Cholera Vaccines Revenue Market Share by Type (2017-2022)
    Table 27. Global Cholera Vaccines Forecasted Market Size by Type (2023-2028) & (US$ Million)
    Table 28. Global Cholera Vaccines Revenue Market Share by Type (2023-2028)
    Table 29. Global Cholera Vaccines Market Size by Application (2017-2022) & (US$ Million)
    Table 30. Global Cholera Vaccines Revenue Share by Application (2017-2022)
    Table 31. Global Cholera Vaccines Forecasted Market Size by Application (2023-2028) & (US$ Million)
    Table 32. Global Cholera Vaccines Revenue Share by Application (2023-2028)
    Table 33. North America Cholera Vaccines Market Size by Type (2017-2022) & (US$ Million)
    Table 34. North America Cholera Vaccines Market Size by Type (2023-2028) & (US$ Million)
    Table 35. North America Cholera Vaccines Market Size by Application (2017-2022) & (US$ Million)
    Table 36. North America Cholera Vaccines Market Size by Application (2023-2028) & (US$ Million)
    Table 37. North America Cholera Vaccines Market Size by Country (2017-2022) & (US$ Million)
    Table 38. North America Cholera Vaccines Market Size by Country (2023-2028) & (US$ Million)
    Table 39. Europe Cholera Vaccines Market Size by Type (2017-2022) & (US$ Million)
    Table 40. Europe Cholera Vaccines Market Size by Type (2023-2028) & (US$ Million)
    Table 41. Europe Cholera Vaccines Market Size by Application (2017-2022) & (US$ Million)
    Table 42. Europe Cholera Vaccines Market Size by Application (2023-2028) & (US$ Million)
    Table 43. Europe Cholera Vaccines Market Size by Country (2017-2022) & (US$ Million)
    Table 44. Europe Cholera Vaccines Market Size by Country (2023-2028) & (US$ Million)
    Table 45. Asia Pacific Cholera Vaccines Market Size by Type (2017-2022) & (US$ Million)
    Table 46. Asia Pacific Cholera Vaccines Market Size by Type (2023-2028) & (US$ Million)
    Table 47. Asia Pacific Cholera Vaccines Market Size by Application (2017-2022) & (US$ Million)
    Table 48. Asia Pacific Cholera Vaccines Market Size by Application (2023-2028) & (US$ Million)
    Table 49. Asia Pacific Cholera Vaccines Market Size by Region (2017-2022) & (US$ Million)
    Table 50. Asia Pacific Cholera Vaccines Market Size by Region (2023-2028) & (US$ Million)
    Table 51. Latin America Cholera Vaccines Market Size by Type (2017-2022) & (US$ Million)
    Table 52. Latin America Cholera Vaccines Market Size by Type (2023-2028) & (US$ Million)
    Table 53. Latin America Cholera Vaccines Market Size by Application (2017-2022) & (US$ Million)
    Table 54. Latin America Cholera Vaccines Market Size by Application (2023-2028) & (US$ Million)
    Table 55. Latin America Cholera Vaccines Market Size by Country (2017-2022) & (US$ Million)
    Table 56. Latin America Cholera Vaccines Market Size by Country (2023-2028) & (US$ Million)
    Table 57. Middle East and Africa Cholera Vaccines Market Size by Type (2017-2022) & (US$ Million)
    Table 58. Middle East and Africa Cholera Vaccines Market Size by Type (2023-2028) & (US$ Million)
    Table 59. Middle East and Africa Cholera Vaccines Market Size by Application (2017-2022) & (US$ Million)
    Table 60. Middle East and Africa Cholera Vaccines Market Size by Application (2023-2028) & (US$ Million)
    Table 61. Middle East and Africa Cholera Vaccines Market Size by Country (2017-2022) & (US$ Million)
    Table 62. Middle East and Africa Cholera Vaccines Market Size by Country (2023-2028) & (US$ Million)
    Table 63. Shantha Biotechnics Private Limited Company Details
    Table 64. Shantha Biotechnics Private Limited Business Overview
    Table 65. Shantha Biotechnics Private Limited Cholera Vaccines Product
    Table 66. Shantha Biotechnics Private Limited Revenue in Cholera Vaccines Business (2017-2022) & (US$ Million)
    Table 67. Shantha Biotechnics Private Limited Recent Developments
    Table 68. PaxVax, Inc. Company Details
    Table 69. PaxVax, Inc. Business Overview
    Table 70. PaxVax, Inc. Cholera Vaccines Product
    Table 71. PaxVax, Inc. Revenue in Cholera Vaccines Business (2017-2022) & (US$ Million)
    Table 72. PaxVax, Inc. Recent Developments
    Table 73. Valneva SE Company Details
    Table 74. Valneva SE Business Overview
    Table 75. Valneva SE Cholera Vaccines Product
    Table 76. Valneva SE Revenue in Cholera Vaccines Business (2017-2022) & (US$ Million)
    Table 77. Valneva SE Recent Developments
    Table 78. Merck and Co., Inc. Company Details
    Table 79. Merck and Co., Inc. Business Overview
    Table 80. Merck and Co., Inc. Cholera Vaccines Product
    Table 81. Merck and Co., Inc. Revenue in Cholera Vaccines Business (2017-2022) & (US$ Million)
    Table 82. Merck and Co., Inc. Recent Developments
    Table 83. GlaxoSmithKline plc (GSK) Company Details
    Table 84. GlaxoSmithKline plc (GSK) Business Overview
    Table 85. GlaxoSmithKline plc (GSK) Cholera Vaccines Product
    Table 86. GlaxoSmithKline plc (GSK) Revenue in Cholera Vaccines Business (2017-2022) & (US$ Million)
    Table 87. GlaxoSmithKline plc (GSK) Recent Developments
    Table 88. Astellas Pharma, Inc. Company Details
    Table 89. Astellas Pharma, Inc. Business Overview
    Table 90. Astellas Pharma, Inc. Cholera Vaccines Product
    Table 91. Astellas Pharma, Inc. Revenue in Cholera Vaccines Business (2017-2022) & (US$ Million)
    Table 92. Astellas Pharma, Inc. Recent Developments
    Table 93. Pfizer, Inc. Company Details
    Table 94. Pfizer, Inc. Business Overview
    Table 95. Pfizer, Inc. Cholera Vaccines Product
    Table 96. Pfizer, Inc. Revenue in Cholera Vaccines Business (2017-2022) & (US$ Million)
    Table 97. Pfizer, Inc. Recent Developments
    Table 98. Emergent BioSolutions, Inc. Company Details
    Table 99. Emergent BioSolutions, Inc. Business Overview
    Table 100. Emergent BioSolutions, Inc. Cholera Vaccines Product
    Table 101. Emergent BioSolutions, Inc. Revenue in Cholera Vaccines Business (2017-2022) & (US$ Million)
    Table 102. Emergent BioSolutions, Inc. Recent Developments
    Table 103. Mitsubishi Tanabe Pharma Corporation Company Details
    Table 104. Mitsubishi Tanabe Pharma Corporation Business Overview
    Table 105. Mitsubishi Tanabe Pharma Corporation Cholera Vaccines Product
    Table 106. Mitsubishi Tanabe Pharma Corporation Revenue in Cholera Vaccines Business (2017-2022) & (US$ Million)
    Table 107. Mitsubishi Tanabe Pharma Corporation Recent Developments
    Table 108. Takeda Pharmaceutical Co., Ltd. Company Details
    Table 109. Takeda Pharmaceutical Co., Ltd. Business Overview
    Table 110. Takeda Pharmaceutical Co., Ltd. Cholera Vaccines Product
    Table 111. Takeda Pharmaceutical Co., Ltd. Revenue in Cholera Vaccines Business (2017-2022) & (US$ Million)
    Table 112. Takeda Pharmaceutical Co., Ltd. Recent Developments
    Table 113. Research Programs/Design for This Report
    Table 114. Key Data Information from Secondary Sources
    Table 115. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Cholera Vaccines Market Share by Type: 2021 VS 2028
    Figure 2. Dukoral Features
    Figure 3. Shanchol Features
    Figure 4. Vaxchora Features
    Figure 5. Others Features
    Figure 6. Global Cholera Vaccines Market Share by Application: 2021 VS 2028
    Figure 7. Oral Case Studies
    Figure 8. Others Case Studies
    Figure 9. Cholera Vaccines Report Years Considered
    Figure 10. Global Cholera Vaccines Market Size (US$ Million), Year-over-Year: 2017-2028
    Figure 11. Global Cholera Vaccines Market Size, (US$ Million), 2017 VS 2021 VS 2028
    Figure 12. Global Cholera Vaccines Market Share by Region: 2021 VS 2028
    Figure 13. Global Cholera Vaccines Market Share by Players in 2021
    Figure 14. Global Top Cholera Vaccines Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cholera Vaccines as of 2021)
    Figure 15. The Top 10 and 5 Players Market Share by Cholera Vaccines Revenue in 2021
    Figure 16. North America Cholera Vaccines Market Size YoY (2017-2028) & (US$ Million)
    Figure 17. North America Cholera Vaccines Market Size Market Share by Type (2017-2028)
    Figure 18. North America Cholera Vaccines Market Size Market Share by Application (2017-2028)
    Figure 19. North America Cholera Vaccines Market Size Share by Country (2017-2028)
    Figure 20. United States Cholera Vaccines Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 21. Canada Cholera Vaccines Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 22. Europe Cholera Vaccines Market Size YoY (2017-2028) & (US$ Million)
    Figure 23. Europe Cholera Vaccines Market Size Market Share by Type (2017-2028)
    Figure 24. Europe Cholera Vaccines Market Size Market Share by Application (2017-2028)
    Figure 25. Europe Cholera Vaccines Market Size Share by Country (2017-2028)
    Figure 26. Germany Cholera Vaccines Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 27. France Cholera Vaccines Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 28. U.K. Cholera Vaccines Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 29. Italy Cholera Vaccines Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 30. Russia Cholera Vaccines Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 31. Nordic Countries Cholera Vaccines Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 32. Asia-Pacific Cholera Vaccines Market Size YoY (2017-2028) & (US$ Million)
    Figure 33. Asia Pacific Cholera Vaccines Market Size Market Share by Type (2017-2028)
    Figure 34. Asia Pacific Cholera Vaccines Market Size Market Share by Application (2017-2028)
    Figure 35. Asia Pacific Cholera Vaccines Market Size Share by Region (2017-2028)
    Figure 36. China Cholera Vaccines Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 37. Japan Cholera Vaccines Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 38. South Korea Cholera Vaccines Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 39. Southeast Asia Cholera Vaccines Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 40. India Cholera Vaccines Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 41. Australia Cholera Vaccines Market Size YoY Growth (2017-2028) & (US$ Million)
List of Figures
    Figure 42. Latin America Cholera Vaccines Market Size YoY (2017-2028) & (US$ Million)
    Figure 43. Latin America Cholera Vaccines Market Size Market Share by Type (2017-2028)
    Figure 44. Latin America Cholera Vaccines Market Size Market Share by Application (2017-2028)
    Figure 45. Latin America Cholera Vaccines Market Size Share by Country (2017-2028)
    Figure 46. Mexico Cholera Vaccines Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 47. Brazil Cholera Vaccines Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 48. Middle East & Africa Cholera Vaccines Market Size YoY (2017-2028) & (US$ Million)
    Figure 49. Middle East and Africa Cholera Vaccines Market Size Market Share by Type (2017-2028)
    Figure 50. Middle East and Africa Cholera Vaccines Market Size Market Share by Application (2017-2028)
    Figure 51. Middle East and Africa Cholera Vaccines Market Size Share by Country (2017-2028)
    Figure 52. Turkey Cholera Vaccines Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 53. Saudi Arabia Cholera Vaccines Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 54. UAE Cholera Vaccines Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 55. Shantha Biotechnics Private Limited Revenue Growth Rate in Cholera Vaccines Business (2017-2022)
    Figure 56. PaxVax, Inc. Revenue Growth Rate in Cholera Vaccines Business (2017-2022)
    Figure 57. Valneva SE Revenue Growth Rate in Cholera Vaccines Business (2017-2022)
    Figure 58. Merck and Co., Inc. Revenue Growth Rate in Cholera Vaccines Business (2017-2022)
    Figure 59. GlaxoSmithKline plc (GSK) Revenue Growth Rate in Cholera Vaccines Business (2017-2022)
    Figure 60. Astellas Pharma, Inc. Revenue Growth Rate in Cholera Vaccines Business (2017-2022)
    Figure 61. Pfizer, Inc. Revenue Growth Rate in Cholera Vaccines Business (2017-2022)
    Figure 62. Emergent BioSolutions, Inc. Revenue Growth Rate in Cholera Vaccines Business (2017-2022)
    Figure 63. Mitsubishi Tanabe Pharma Corporation Revenue Growth Rate in Cholera Vaccines Business (2017-2022)
    Figure 64. Takeda Pharmaceutical Co., Ltd. Revenue Growth Rate in Cholera Vaccines Business (2017-2022)
    Figure 65. Bottom-up and Top-down Approaches for This Report
    Figure 66. Data Triangulation
    Figure 67. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Shantha Biotechnics Private Limited
PaxVax, Inc.
Valneva SE
Merck and Co., Inc.
GlaxoSmithKline plc (GSK)
Astellas Pharma, Inc.
Pfizer, Inc.
Emergent BioSolutions, Inc.
Mitsubishi Tanabe Pharma Corporation
Takeda Pharmaceutical Co., Ltd.
Frequently Asked Questions
Cholera Vaccines report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Cholera Vaccines report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Cholera Vaccines report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports